Search Results 851-860 of 17128 for monoclonal antibody

  1. Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) - Mayo Clinic

    Prior immunotherapy & monoclonal antibody therapy are acceptable. Subjects who received prior cytotoxic chemotherapy after incomplete resection of ...

  2. CNS Autoantibody and Inflammatory Marker Investigation in Catatonia - Mayo Clinic

    CNS Autoantibody and Inflammatory Marker Investigation in Catatonia · Overview · Participation eligibility · Participating Mayo Clinic locations · More information ...

  3. Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 - Mayo Clinic

    infusion reaction or hypersensitivity (CTCAE Grade 3 or higher) with monoclonal antibody treatment - Clinically significant cardiac disease, including but ...

  4. A Phase 1-2 Multi-Center Study Evaluating Axicabtagene Ciloleucel in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) - Mayo Clinic

    anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative; and; an anthracycline containing chemotherapy regimen;; for subjects ...

  5. Diseases and Conditions that Start with M - Mayo Clinic

    Monoclonal gammopathy of undetermined significance (MGUS) ... MOG antibody-associated disorder. See. Myelin ... Monoclonal gammopathy of undetermined significance ( ...

  6. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Chemotherapy, small molecule inhibitors, radiation, and/or other investigational anticancer agents (excluding investigational monoclonal antibodies): within 2 ...

  7. Translational Science - 2020 Archives - Mayo Clinic News Network

    Science Saturday: COVID-19 experimental antibody treatment reaches patients ... Convalescent Plasma: A Therapy for COVID-19? Kate Ledger. April 6, 2020. Science ...

  8. Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab - Mayo Clinic

    The purpose of this study is to evaluate T cell and antibody immunity in patients with HER2+ breast cancer who will receive trastuzumab with standard ...

  9. Influenza - Vaccines: Gregory A. Poland, Richard B. Kennedy - Mayo Clinic Research

    This study aims to characterize and compare the humoral immune response to trivalent influenza vaccine among people with monoclonal B cell lymphocytosis and ...

  10. MEDI5395 Advanced Solid Tumors - Mayo Clinic

    At least 28 days must have elapsed since non-immunotherapy monoclonal antibody treatment (for example trastuzumab, cetuximab, bevacizumab, or panitumumab); ...